T 0108/09 (Fulvestrant for treating resistant breast cancer/ASTRA ZENECA AB) of 14.2.2013

European Case Law Identifier: ECLI:EP:BA:2013:T010809.20130214
Date of decision: 14 February 2013
Case number: T 0108/09
Application number: 01917289.9
IPC class: A61K 31/565
A61P 35/00
Language of proceedings: EN
Distribution: D
Download and more information:
Decision text in EN (PDF, 148.493K)
Documentation of the appeal procedure can be found in the Register
Bibliographic information is available in: EN
Versions: Unpublished
Title of application: Use of fulvestrant in the treatment of resistant breast cancer
Applicant name: AstraZeneca AB
Opponent name: Teva Pharmaceutical Industries Ltd.
Board: 3.3.02
Headnote: -
Relevant legal provisions:
European Patent Convention Art 54
European Patent Convention Art 56
European Patent Convention Art 83
European Patent Convention Art 123(2)
Keywords: Added matter (no)
Sufficiency of disclosure, novelty and inventive step (yes)
Catchwords:

-

Cited decisions:
G 0005/83
G 0001/03
G 0002/08
T 0019/86
T 0893/90
T 0233/96
T 1319/04
T 1329/04
T 0425/09
Citing decisions:
T 0488/16
T 1868/16

16 references found.

Click X to load a reference inside the current page, click on the title to open in a new page.

EPC Articles

Offical Journal of the EPO

Case Law Book: I Patentability

Case Law of the Enlarged Board

General Case Law